The expression of prolactin receptors in benign breast tumors is not associated with serum prolactin level

Autor: Olena Kolomiiets, Oleksandr Yazykov, Artem Piddubnyi, Mykola Lyndin, Ivan Lukavenko, Volodymyr Andryushchenko, Anatolii Romaniuk, Roman Moskalenko

Publikováno v: Journal of Clinical Medicine, Vol 10, Iss 5866, p 5866 (2021)
Journal of Clinical Medicine
Journal of Clinical Medicine; Volume 10; Issue 24; Pages: 5866

The role of prolactin (PRL) and its receptors in the initiation and development of benign breast tumors (BBT) has not been sufficiently studied. An imbalance in the system of hormone homeostasis is crucial in the development of BBT. In particular, an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d88a3132edf0e376322484a8b8c834b
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-190813